IL158698A0 - Agent for improving tissue penetration - Google Patents

Agent for improving tissue penetration

Info

Publication number
IL158698A0
IL158698A0 IL15869802A IL15869802A IL158698A0 IL 158698 A0 IL158698 A0 IL 158698A0 IL 15869802 A IL15869802 A IL 15869802A IL 15869802 A IL15869802 A IL 15869802A IL 158698 A0 IL158698 A0 IL 158698A0
Authority
IL
Israel
Prior art keywords
agent
tissue penetration
improving tissue
diluents
active agent
Prior art date
Application number
IL15869802A
Other languages
English (en)
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of IL158698A0 publication Critical patent/IL158698A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL15869802A 2001-05-11 2002-05-13 Agent for improving tissue penetration IL158698A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10122855A DE10122855A1 (de) 2001-05-11 2001-05-11 Mittel zur Verbesserung der Gewebepenetration
PCT/EP2002/005242 WO2002092130A1 (en) 2001-05-11 2002-05-13 Agent for improving tissue penetration

Publications (1)

Publication Number Publication Date
IL158698A0 true IL158698A0 (en) 2004-05-12

Family

ID=7684371

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15869802A IL158698A0 (en) 2001-05-11 2002-05-13 Agent for improving tissue penetration

Country Status (11)

Country Link
US (5) US20040146535A1 (ja)
EP (1) EP1387699B1 (ja)
JP (1) JP5433866B2 (ja)
KR (1) KR100604435B1 (ja)
AT (1) ATE346615T1 (ja)
AU (1) AU2002342304B2 (ja)
CA (1) CA2446659C (ja)
DE (2) DE10122855A1 (ja)
IL (1) IL158698A0 (ja)
NZ (1) NZ529142A (ja)
WO (1) WO2002092130A1 (ja)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098713A (en) * 1975-12-24 1978-07-04 The Procter & Gamble Company Detergent compositions
JPS6028946A (ja) * 1983-07-28 1985-02-14 Kao Corp テルペンアルコ−ルのジグリセリンアルキルエ−テル及びこれを含有する化粧料
ATE36807T1 (de) * 1983-12-01 1988-09-15 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran.
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
JPS61205277A (ja) * 1985-03-08 1986-09-11 Pola Chem Ind Inc 新規エポキシ化合物
US6121246A (en) * 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
JP2000506121A (ja) * 1996-02-16 2000-05-23 マツクス―プランク―ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ ホスファチジルオリゴグリセリン
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
JP2000143441A (ja) * 1998-11-10 2000-05-23 Kao Corp メイクアップ除去剤
DE19959000B4 (de) * 1999-12-08 2018-07-05 Cognis Ip Management Gmbh Verwendung primärer Monoalkylether von Eigenkondensationsprodukten des Glycerins
KR100393478B1 (ko) * 2000-03-29 2003-08-06 주식회사종근당 자가유화 매트릭스형 경점막·경피흡수제제

Also Published As

Publication number Publication date
DE10122855A1 (de) 2002-11-14
CA2446659A1 (en) 2002-11-21
DE60216441D1 (de) 2007-01-11
US20080003277A1 (en) 2008-01-03
EP1387699A1 (en) 2004-02-11
US20120064147A1 (en) 2012-03-15
US20040146535A1 (en) 2004-07-29
DE60216441T2 (de) 2007-03-15
EP1387699B1 (en) 2006-11-29
ATE346615T1 (de) 2006-12-15
AU2002342304B2 (en) 2007-11-29
CA2446659C (en) 2011-08-16
WO2002092130A1 (en) 2002-11-21
NZ529142A (en) 2004-09-24
JP5433866B2 (ja) 2014-03-05
US20090312440A1 (en) 2009-12-17
JP2004530688A (ja) 2004-10-07
KR20030097858A (ko) 2003-12-31
KR100604435B1 (ko) 2006-07-25
US20160031781A1 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
BE2017C018I2 (ja)
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
LU91854I2 (fr) Eribulin et ses dérivés pharmaceutiquement acceptables (HALAVEN®)
MXPA03011981A (es) 3-fluoruro-pirrolidinas como agentes antidiabeticos.
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
BG106013A (en) New compounds and compositions as protease inhibitors
EP1477186A4 (en) antipruritics
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
DE69931393D1 (de) Antithrombotische amide
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
BR0012696A (pt) Composição oftálmica
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
PT1408966E (pt) Combinações farmacêuticas sinergísticas para a prevenção ou tratamento da diabetes
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MXPA03001081A (es) Medicamento anti-inflamatorio.
AU2001282871A1 (en) Antithrombotic agents
SE0004101D0 (sv) New use
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
MXPA03005922A (es) Metodo para tratar glaucoma ib.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed